跳至主要内容
临床试验/KCT0003703
KCT0003703招募中未知

Registry of Effects of high-dose Rosuvastatin and Atorvastatin on Cystatin C-Oriented cOntrast induced Nephropathy in patients of Acute Myocardial Infarction(RACCOON-AMI Registry)

Kangbuk Samsung Medical Center0 个研究点目标入组 460 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
460

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • [Inclusion Criteria]
  • 1) Male and Female aged 20 or over
  • 2) Non-ST elevation MI or STEMI
  • 3) Atorvastatin(40mg) or Rosuvastatin(20mg) used for the reduction of cholesterol
  • 4) High-intensity statin(atorvastatin 40mg, 80mg, rosuvastatin 20mg) never used or statin-naive
  • **Including intensity of below moderate statin.
  • (moderate intensity statins: rosuvastatin 10mg, atorvastatin 20mg, simvastatin/ezetimibe(vytorin) 10/20mg, simvastatin 40mg, pitavastatin 2mg, fluvastatin XL 80mg, pravastatin 40mg)

排除标准

  • [Exclusion Criteria]
  • 1) Cardiogenic shock
  • 2) Iodinated contrast media administration within the previous 10 days
  • 3) high-intensity statin being used(rosuvastatin 20mg, atorvastatin 40mg or 80mg)
  • 4) Current hemo-dialysis or peritoneal dialysis
  • 5) Thyroid diseases
  • 6) An allergy to the radiocontrast medium
  • 7) Patients who should ban statin
  • 8) Pregnancy
  • 9) Refusal of consent

研究者

相似试验